These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26779022)

  • 1. Entecavir Interacts with Influx Transporters hOAT1, hCNT2, hCNT3, but Not with hOCT2: The Potential for Renal Transporter-Mediated Cytotoxicity and Drug-Drug Interactions.
    Mandíková J; Volková M; Pávek P; Navrátilová L; Hyršová L; Janeba Z; Pavlík J; Bárta P; Trejtnar F
    Front Pharmacol; 2015; 6():304. PubMed ID: 26779022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
    Mandíková J; Volková M; Pávek P; Česnek M; Janeba Z; Kubíček V; Trejtnar F
    Toxicology; 2013 Sep; 311(3):135-46. PubMed ID: 23856525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).
    Uwai Y; Ida H; Tsuji Y; Katsura T; Inui K
    Pharm Res; 2007 Apr; 24(4):811-5. PubMed ID: 17372702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal handling of amphotericin B and amphotericin B-deoxycholate and potential renal drug-drug interactions with selected antivirals.
    Trejtnar F; Mandíková J; Kočíncová J; Volková M
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5650-7. PubMed ID: 24957831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Drug Transporters Are Involved in Renal Secretion of Entecavir.
    Yang X; Ma Z; Zhou S; Weng Y; Lei H; Zeng S; Li L; Jiang H
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6260-70. PubMed ID: 27503646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1.
    Cihlar T; Lin DC; Pritchard JB; Fuller MD; Mendel DB; Sweet DH
    Mol Pharmacol; 1999 Sep; 56(3):570-80. PubMed ID: 10462545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy Impacts Entecavir Pharmacokinetics but Does Not Alter Its Renal Excretion.
    Lu S; Yang X; Jiang T; Zhou H; Wang W; Lin N; Zeng S; Ma Z; Jiang H
    J Pharm Sci; 2020 May; 109(5):1811-1818. PubMed ID: 32027922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal transporters in drug disposition, drug-drug interactions, and nephrotoxicity.
    Feng B; El-Kattan AF; Radi ZA
    Curr Protoc Toxicol; 2012 Aug; Chapter 23():Unit 23.3.1-15. PubMed ID: 22896010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human organic anion transporter 2 is an entecavir, but not tenofovir, transporter.
    Furihata T; Morio H; Zhu M; Suzuki Y; Ide H; Tsubota A; Fu Z; Anzai N; Chiba K
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):116-119. PubMed ID: 27916488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3.
    Smith KM; Slugoski MD; Cass CE; Baldwin SA; Karpinski E; Young JD
    Mol Membr Biol; 2007; 24(1):53-64. PubMed ID: 17453413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
    Park JG; Park SY
    Clin Mol Hepatol; 2015 Sep; 21(3):242-8. PubMed ID: 26523269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1.
    Mulato AS; Ho ES; Cihlar T
    J Pharmacol Exp Ther; 2000 Oct; 295(1):10-5. PubMed ID: 10991954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular concentrations determine the cytotoxicity of adefovir, cidofovir and tenofovir.
    Zhang X; Wang R; Piotrowski M; Zhang H; Leach KL
    Toxicol In Vitro; 2015 Feb; 29(1):251-8. PubMed ID: 25448811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.
    Takeda M; Khamdang S; Narikawa S; Kimura H; Kobayashi Y; Yamamoto T; Cha SH; Sekine T; Endou H
    J Pharmacol Exp Ther; 2002 Mar; 300(3):918-24. PubMed ID: 11861798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple SLC and ABC Transporters Contribute to the Placental Transfer of Entecavir.
    Ma Z; Yang X; Jiang T; Bai M; Zheng C; Zeng S; Sun D; Jiang H
    Drug Metab Dispos; 2017 Mar; 45(3):269-278. PubMed ID: 28062543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial.
    Lim YS; Yoo BC; Byun KS; Kwon SY; Kim YJ; An J; Lee HC; Lee YS
    Gut; 2016 Jun; 65(6):1042-51. PubMed ID: 25800784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs.
    Cihlar T; Ho ES; Lin DC; Mulato AS
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):641-8. PubMed ID: 11563082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy.
    Kim JH; Ahn SH; Ko SY; Choe WH; Kim KH; Kwon SY
    Clin Mol Hepatol; 2016 Jun; 22(2):241-9. PubMed ID: 27304549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein.
    Chu XY; Bleasby K; Yabut J; Cai X; Chan GH; Hafey MJ; Xu S; Bergman AJ; Braun MP; Dean DC; Evers R
    J Pharmacol Exp Ther; 2007 May; 321(2):673-83. PubMed ID: 17314201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Efficacy of Tenofovir Versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients With Poor Efficacy of Entecavir: A Systematic Review and Meta-analysis.
    Chen J; Zhao SS; Liu XX; Huang ZB; Huang Y
    Clin Ther; 2017 Sep; 39(9):1870-1880. PubMed ID: 28797777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.